{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:38:57Z","timestamp":1791466737331,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de S\u00e3o Paulo","award":["#2009\/00465-9"],"award-info":[{"award-number":["#2009\/00465-9"]}]},{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de S\u00e3o Paulo","award":["#2010\/20200-6"],"award-info":[{"award-number":["#2010\/20200-6"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#472507\/2009-5"],"award-info":[{"award-number":["#472507\/2009-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Funda\u00e7\u00e3o Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Associa\u00e7\u00e3o Fundo de Pesquisa \u00e0 Pesquisa"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.pnpbp.2015.05.015","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T00:22:25Z","timestamp":1433550145000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Effects of prenatal immune activation on amphetamine-induced addictive behaviors: Contributions from animal models"],"prefix":"10.1016","volume":"63","author":[{"given":"Aline R.","family":"Bor\u00e7oi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3926-9448","authenticated-orcid":false,"given":"Camilla L.","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina A.","family":"Zanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 W.","family":"Hollais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan","family":"Santos-Baldaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliane M.B.","family":"Ceccon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00eds F.","family":"Berro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Wuo-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B.","family":"Grapiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana T.C.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo B.","family":"Lopes-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Frussa-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2015.05.015_bb0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/exnr.1995.1082","article-title":"Interleukin-1 beta enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons","volume":"136","author":"Akaneya","year":"1995","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.brainresrev.2007.07.014","article-title":"Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective","volume":"56","author":"Alcaro","year":"2007","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: what does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0020","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/archpsyc.63.4.426","article-title":"A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness","volume":"63","author":"Bellack","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0165-0173(98)00019-8","article-title":"What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?","volume":"28","author":"Berridge","year":"1998","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pbb.2014.05.001","article-title":"Sleep deprivation impairs the extinction of cocaine-induced environmental conditioning in mice","volume":"124","author":"Berro","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2014.04.013","article-title":"Maternal prenatal infection, early susceptibility to illness and adult psychotic experiences: a birth cohort study","volume":"156","author":"Betts","year":"2014","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0272-7358(99)00033-1","article-title":"Substance use disorders in schizophrenia: review, integration, and a proposed model","volume":"20","author":"Blanchard","year":"2000","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0045","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbi.2010.03.005","article-title":"Effects of prenatal infection on brain development and behavior: a review of findings from animal models","volume":"24","author":"Boksa","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0050","first-page":"PL1","article-title":"Context-dependent cross-sensitization between cocaine and amphetamine","volume":"60","author":"Bonate","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/brbi.2001.0644","article-title":"Maternal cytokine levels during pregnancy and adult psychosis","volume":"15","author":"Buka","year":"2001","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/73949","article-title":"A measure of striatal function predicts motor stereotypy","volume":"3","author":"Canales","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0075","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2478\/s13380-012-0045-6","article-title":"Prenatal infection, maternal immune activation and risk for schizophrenia","volume":"3","author":"Canetta","year":"2012","journal-title":"Transl Neurosci"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1369-1600.2008.00145.x","article-title":"Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors","volume":"14","author":"Carvalho","year":"2009","journal-title":"Addict Biol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/exnr.2001.7735","article-title":"A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease","volume":"171","author":"Carvey","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.npp.1300789","article-title":"Characterization of the rapid-onset type of behavioral sensitization to amphetamine in mice: role of drug\u2013environment conditioning","volume":"31","author":"Chinen","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.npep.2006.12.001","article-title":"Blockade of neurotensin receptors during amphetamine discontinuation indicates individual variability","volume":"41","author":"Costa","year":"2007","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0100","first-page":"R759","article-title":"The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism","volume":"287","author":"Fortier","year":"2004","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0105","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.pnpbp.2007.01.025","article-title":"Haloperidol (but not ziprasidone) withdrawal enhances cocaine-induced locomotor activation and conditioned place preference in mice","volume":"31","author":"Fukushiro","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainresbull.2008.05.004","article-title":"Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice","volume":"77","author":"Fukushiro","year":"2008","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0120","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.npp.1300446","article-title":"Prenatal infection and risk for schizophrenia: IL-1b, IL-6, and TNFa inhibit cortical neuron dendrite development","volume":"29","author":"Gilmore","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2004.10.008","article-title":"Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal\u2013fetal unit of the rat","volume":"159","author":"Gilmore","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0125","first-page":"21","article-title":"Schizophrenia and comorbid substance use disorder: effects of antipsychotics","volume":"66","author":"Green","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.cpr.2006.09.004","article-title":"Reasons for increased substance use in psychosis","volume":"27","author":"Gregg","year":"2007","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neures.2009.03.015","article-title":"Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood","volume":"64","author":"Ibi","year":"2009","journal-title":"Neurosci Res"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking esquizofrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0145","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","article-title":"Animal models of schizophrenia","volume":"164","author":"Jones","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0150","series-title":"Neurocircuitry of addiction. Neuropsychopharmacology, the fifth generation of progress","first-page":"1357","author":"Kalivas","year":"2002"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb2000","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.npp.1301564","article-title":"Drug addiction as a pathology of staged neuroplasticity","volume":"33","author":"Kalivas","year":"2008","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.1992.tb25966.x","article-title":"Neural mechanisms of drug reinforcement","volume":"54","author":"Koob","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/23.2.181","article-title":"Substance abuse and schizophrenia: editors' introduction","volume":"23","author":"Kosten","year":"1997","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/exnr.1998.6715","article-title":"Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines","volume":"149","author":"Ling","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1017\/S1461145713001430","article-title":"Selective action of an atypical neuroleptic on the mechanisms related to the development of cocaine addiction: a pre-clinical behavioural study","volume":"17","author":"Marinho","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0180","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neubiorev.2004.10.012","article-title":"Towards an immunoprecipitated neurodevelopmental animal model of schizophrenia","volume":"29","author":"Meyer","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00221-006-0419-5","article-title":"Prenatal and postnatal maternal contributions in the infection model of schizophrenia","volume":"173","author":"Meyer","year":"2006","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0190","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1523\/JNEUROSCI.0099-06.2006","article-title":"The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology","volume":"26","author":"Meyer","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0195","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1073858406296401","article-title":"The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?","volume":"13","author":"Meyer","year":"2007","journal-title":"Neuroscientist"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0200","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.mp.4002042","article-title":"Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated antiinflammatory signaling","volume":"13","author":"Meyer","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0205","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2007.09.012","article-title":"Adult brain and behavioral pathological markers of prenatal immune challenge during early\/middle and late fetal development in mice","volume":"22","author":"Meyer","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0210","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.neuroscience.2008.04.031","article-title":"Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy","volume":"154","author":"Meyer","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0215","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.neubiorev.2009.05.001","article-title":"In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders","volume":"33","author":"Meyer","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0220","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbr.2013.10.052","article-title":"Repetitive behavior profile and supersensitivity to amphetamine in the C58\/J mouse model of autism","volume":"259","author":"Moy","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0225","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1248\/bpb.34.1364","article-title":"Animal model for schizophrenia that reflects gene\u2013environment interactions. Translational research in neurodevelopmental disorders: development of etiology-based animal models","volume":"34","author":"Nagai","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0230","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopsych.2005.07.031","article-title":"Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia","volume":"59","author":"Ozawa","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0235","doi-asserted-by":"crossref","first-page":"21968","DOI":"10.3402\/qhw.v8i0.21968","article-title":"Walking the fine line: self-reported reasons for substance use in persons with severe mental illness","volume":"8","author":"Pettersen","year":"2013","journal-title":"Int J Qual Stud Health Well-being"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0240","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/schbul\/sbq040","article-title":"Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia","volume":"37","author":"Piontkewitz","year":"2011","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s004410051285","article-title":"Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons","volume":"296","author":"Potter","year":"1999","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0250","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.mp.4001642","article-title":"The neurodevelopmental model of schizophrenia: update","volume":"10","author":"Rapoport","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0255","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00213-012-2646-8","article-title":"Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat","volume":"222","author":"Richtand","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis","volume":"396","author":"Robinson","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0265","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: an incentive-sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0270","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1360-0443.2001.9611038.x","article-title":"Incentive-sensitization and addiction","volume":"96","author":"Robinson","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0275","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1098\/rstb.2008.0093","article-title":"The incentive sensitization theory of addiction: some current issues","volume":"363","author":"Robinson","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0280","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/mp.2008.44","article-title":"Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia","volume":"15","author":"Romero","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2013.11.032","article-title":"Acute total sleep deprivation potentiates amphetamine-induced locomotor-stimulant effects and behavioral sensitization in mice","volume":"117","author":"Saito","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0290","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1523\/JNEUROSCI.1072-04.2004","article-title":"Repetitive behaviors in monkeys are linked to specific striatal activation patterns","volume":"24","author":"Saka","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0295","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1369-1600.2006.00012.x","article-title":"Behavioural assessment of drug reinforcement and addictive features in rodents: an overview","volume":"11","author":"Sanchis-Segura","year":"2006","journal-title":"Addict Biol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0300","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(76)90119-9","article-title":"Differential attenuation of some effects of haloperidol in rats given scopolamine","volume":"39","author":"Setler","year":"1976","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0305","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nature09563","article-title":"The environment and schizophrenia","volume":"468","author":"Van Os","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0310","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.neubiorev.2003.11.001","article-title":"Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs","volume":"27","author":"Vezina","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0315","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/syn.21561","article-title":"Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC","volume":"66","author":"Vorhees","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0320","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ntt.2014.10.007","article-title":"Prenatal immune challenge in rats: effects of polyinosinic\u2013polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine","volume":"47","author":"Vorhees","year":"2015","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0325","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"A psychomotor stimulant theory of addiction","volume":"94","author":"Wise","year":"1987","journal-title":"Psychol Rev"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0330","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1369-1600.2011.00341.x","article-title":"Addictive potential of modafinil and cross-sensitization with cocaine: a pre-clinical study","volume":"16","author":"Wuo-Silva","year":"2011","journal-title":"Addict Biol"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0335","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbr.2012.03.036","article-title":"Maternal immune activation in late gestation enhances locomotor response to acute but not chronic amphetamine treatment in male mice offspring: role of the D1 receptor","volume":"232","author":"Zager","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0345","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpsychires.2004.08.008","article-title":"Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring","volume":"39","author":"Zuckerman","year":"2005","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2015.05.015_bb0340","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/sj.npp.1300248","article-title":"Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia","volume":"28","author":"Zuckerman","year":"2003","journal-title":"Neuropsychopharmacology"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584615001256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584615001256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T04:32:47Z","timestamp":1566793967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584615001256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":68,"alternative-id":["S0278584615001256"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.05.015","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of prenatal immune activation on amphetamine-induced addictive behaviors: Contributions from animal models","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}